Nuveen Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$4.75M Hold
44,296
﹤0.01% 2010
2024
Q3
$4.43M Buy
44,296
+481
+1% +$48.1K ﹤0.01% 2042
2024
Q2
$3.69M Buy
43,815
+778
+2% +$65.6K ﹤0.01% 2096
2024
Q1
$3.15M Hold
43,037
﹤0.01% 2184
2023
Q4
$3.07M Buy
43,037
+372
+0.9% +$26.6K ﹤0.01% 2212
2023
Q3
$2.56M Sell
42,665
-42,314
-50% -$2.54M ﹤0.01% 2201
2023
Q2
$6.13M Buy
84,979
+20,349
+31% +$1.47M ﹤0.01% 1794
2023
Q1
$4.75M Buy
64,630
+19,636
+44% +$1.44M ﹤0.01% 1920
2022
Q4
$3.01M Sell
44,994
-38,198
-46% -$2.55M ﹤0.01% 2194
2022
Q3
$4.47M Sell
83,192
-2,280
-3% -$122K ﹤0.01% 1970
2022
Q2
$4.76M Sell
85,472
-1,359
-2% -$75.6K ﹤0.01% 1981
2022
Q1
$6.11M Sell
86,831
-2,047
-2% -$144K ﹤0.01% 1953
2021
Q4
$7.71M Sell
88,878
-6,784
-7% -$588K ﹤0.01% 1843
2021
Q3
$8.64M Sell
95,662
-56,416
-37% -$5.09M ﹤0.01% 1881
2021
Q2
$12.4M Sell
152,078
-3,193
-2% -$261K ﹤0.01% 1722
2021
Q1
$14.8M Buy
155,271
+44,444
+40% +$4.23M ﹤0.01% 1545
2020
Q4
$6.88M Sell
110,827
-3,239
-3% -$201K ﹤0.01% 1910
2020
Q3
$6.78M Sell
114,066
-3,961
-3% -$236K ﹤0.01% 1754
2020
Q2
$8.24M Sell
118,027
-71,760
-38% -$5.01M ﹤0.01% 1621
2020
Q1
$8.61M Buy
189,787
+13,914
+8% +$631K ﹤0.01% 1389
2019
Q4
$11.4M Sell
175,873
-7,364
-4% -$479K ﹤0.01% 1508
2019
Q3
$11.4M Sell
183,237
-460
-0.3% -$28.6K ﹤0.01% 1481
2019
Q2
$13.1M Buy
+183,697
New +$13.1M 0.01% 1430
2019
Q1
Sell
-17,625
Closed -$1.49M 1051
2018
Q4
$1.49M Sell
17,625
-774
-4% -$65.5K 0.01% 650
2018
Q3
$3.15M Sell
18,399
-882
-5% -$151K 0.02% 588
2018
Q2
$2.49M Buy
19,281
+2,767
+17% +$358K 0.02% 593
2018
Q1
$1.7M Buy
16,514
+1,685
+11% +$174K 0.01% 640
2017
Q4
$1.27M Sell
14,829
-387
-3% -$33.1K 0.01% 686
2017
Q3
$1.29M Buy
15,216
+5,220
+52% +$443K 0.01% 698
2017
Q2
$757K Sell
9,996
-1,554
-13% -$118K ﹤0.01% 815
2017
Q1
$763K Buy
+11,550
New +$763K ﹤0.01% 1053